| Trial ID: | L3646 |
| Source ID: | NCT00948168
|
| Associated Drug: |
Exenatide (Byetta)
|
| Title: |
Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: exenatide (Byetta)
|
| Outcome Measures: |
Primary: Improvement in HbA1c, 6 months | Secondary: Non-invasive modeling of glucose homeostasis determinants, including insulin sensitivity, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-07
|
| Completion Date: |
2009-07
|
| Results First Posted: |
|
| Last Update Posted: |
2009-07-31
|
| Locations: |
Cliniques universitaires St-Luc, Brussels, Brabant, 1200, Belgium
|
| URL: |
https://clinicaltrials.gov/show/NCT00948168
|
